Login / Signup

Efficacy and Safety of Ganyushu Granule in Treatment of Premenstrual Syndrome with Gan (Liver) Depression and Qi Stagnation Syndrome: A Randomized, Double-Blind, Multicenter, Phase-II Clinical Trial.

Xiu-Xiang TengLian-Wei XuJie LinJin-Feng ZhangQin ZhangYun SunDe-Feng YangHong-Mei LiPei ZhaoJun Liu
Published in: Chinese journal of integrative medicine (2024)
GYSG was safe and well-tolerated at both doses for treating PMS patients with GDQSS. High-dose GYSG might be the optimal dose for a phase III trial. (Registration No. ChiCTR1800016595).
Keyphrases
  • phase ii
  • phase iii
  • double blind
  • clinical trial
  • open label
  • placebo controlled
  • high dose
  • case report
  • study protocol
  • low dose
  • stem cell transplantation
  • cross sectional
  • replacement therapy